Cantel Medical (Cantel Medical) Momentum Rank : 0 (As of May. 06, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Cantel Medical Momentum Rank?

Cantel Medical has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Cantel Medical Momentum Rank Related Terms

Thank you for viewing the detailed overview of Cantel Medical's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantel Medical (Cantel Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cantel Medical Corp (NYSE:CMD) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 Clove Road, 9th Floor, Little Falls, NJ, USA, 07424

Website

http://www.cantelmedical.com

Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.

Executives

Ann E Berman	director	255 STATE STREET, BOSTON MA 02109
Jeffrey Z Mann	officer: SVP, General Counsel	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
George L Fotiades	director, officer: Chief Executive Officer	281 SUMMIT AVENUE, SUMMIT NJ 07901
Charles M Diker	director, 10 percent owner, officer: Chairman	ONE NEW YORK PLAZA, NEW YORK NY 10004
Shaun M. Blakeman	officer: SVP - CFO	C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Jean Casner	officer: SVP and CHRO	150 CLOVE ROAD, LITTLE FALLS NJ 07424
Brian Capone	officer: SVP and Princ. Accounting Ofr	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Peter G Clifford	officer: President and COO	40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047
Seth M Yellin	officer: Executive Vice President	150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424
Laura L Forese	director	849 STONEWALL COURT FRANKLIN LAKES NJ 07417
Peter Pronovost	director	JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231
Anthony B Evnin	director	C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Ronnie Myers	director	TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595
Alan R Batkin	director	399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022
Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316